文献速递免疫规划

加纳北部减少序贯外疫苗接种与儿童死亡率下降

Fewer out-of-sequence vaccinations and reduction of child mortality in Northern Ghana.
PubMed 文献 · Vaccine · 2017-03-22

研究利用1996至2012年加纳北部12-23月龄儿童年度队列数据,用Cox比例风险模型分析最近疫苗接种状态与随后12个月及至5岁生存的关系。结果显示含DTP疫苗与MV的序贯外接种从1989年86%降至1996年24%、2012年0.7%;与推荐MV-after-DTP3相比,序贯外接种(DTP>=MV)调整HR为1.42(1.06-1.90),随访至5岁为1.29(1.03-1.60)。作者认为该关联不太可能由混杂所致,序贯外接种减少可能降低了儿童死亡率,并推荐不要DTP与MV同时接种或MV后接种DTP。

要点

  • 序贯外接种(DTP>=MV)与更高死亡风险相关:12个月内调整HR 1.42(1.06-1.90)。
  • 随访至5岁时调整HR为1.29(1.03-1.60),效应方向一致。
  • 作者推荐不要DTP与MV同时接种,也不要在MV后接种DTP。

核心结论

  • 含DTP与MV的序贯外接种与以MV为最近接种相比死亡率更高,该效应不太可能由混杂所致,序贯外接种减少可能降低了儿童死亡率。
  • 作者推荐不要DTP与MV同时接种,也不要在MV后接种DTP。

研究设计与样本

  • 利用1996至2012年加纳北部12-23月龄儿童年度队列数据,采用Cox比例风险模型评估最近疫苗接种状态与随后12个月及至5岁生存的关系。
  • 共对38 070名儿童的疫苗接种状态进行了评估。

主要发现

  • 含DTP疫苗与MV的序贯外接种从1989年86%降至1996年24%、2012年0.7%。
  • 与推荐MV-after-DTP3相比,序贯外接种(DTP>=MV)在评估接种状态后最初12个月的调整HR为1.42(1.06-1.90)。
  • 随访至5岁时调整HR为1.29(1.03-1.60)。
  • 在OPV或MV补充活动前HR为2.58(1.14-5.84),活动后HR为1.37(1.02-1.85)。

关键数值与推荐

  • 评估接种状态后最初12个月,序贯外接种(DTP>=MV)对比MV-after-DTP3的调整HR为1.42(1.06-1.90)。
  • 随访至5岁时,序贯外接种(DTP>=MV)对比MV-after-DTP3的调整HR为1.29(1.03-1.60)。
  • OPV或MV补充活动前,序贯外接种(DTP>=MV)对比MV-after-DTP3的HR为2.58(1.14-5.84);活动后HR为1.37(1.02-1.85)。

临床怎么用

  • 作者推荐不要DTP与MV同时接种,也不要在MV后接种DTP。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Studies suggest that diphtheria-tetanus-pertussis (DTP) vaccine administered simultaneously with measles vaccine (MV) or DTP administered after MV are associated with higher child mortality than having MV-after-DTP3 as most recent vaccination. We tested this in Northern Ghana where the prevalence of such out-of-sequence vaccinations has declined. METHODS: Using annual cohort data of children aged 12-23months from 1996 to 2012 and Cox proportional hazards models, we assessed survival in relation to the most recent vaccination status within the next 12months and until five years of age. We assessed whether mortality in children aged 12-59months was higher when the most recent vaccine was non-live (DTP) rather than live (MV or OPV). RESULTS: Out-of-sequence vaccinations with DTP-containing vaccines and MV declined from 86% in 1989 to 24% in 1996 and 0.7% in 2012. Between 1996 and 2012, 38 070 children had their vaccinations status assessed: the adjusted hazard ratio (HR) for out-of-sequence vaccinations (DTP>=MV) compared with the recommended sequence of MV-after-DTP3 was 1.42(1.06-1.90) during the first 12months after assessment of vaccination status and 1.29(1.03-1.60) with follow-up to five years of age; the HR was 2.58(1.14-5.84) before OPV or MV campaigns and 1.37(1.02-1.85) after the campaigns. CONCLUSION: Out-of-sequence vaccinations with DTP and MV are associated with higher mortality than MV as most recent vaccination; the effect is unlikely to be due to confounding. Hence, the reduction in out-of-sequence vaccinations may have lowered child mortality. It is recommended not to give DTP with MV or DTP after MV.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Welaga P, Oduro A, Debpuur C, et al. Fewer out-of-sequence vaccinations and reduction of child mortality in Northern Ghana. Vaccine. 2017. PMID: 28341115. doi:10.1016/j.vaccine.2017.03.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。